134 related articles for article (PubMed ID: 36472032)
1. [Dissolution test and evaluation of Guizhi Fuling Capsules].
Huang ZB; Wang L; Kang Y; Wang TJ; Wang ZZ; Zhang HD; Bai G; Li Z; Li WL
Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(19):5256-5263. PubMed ID: 36472032
[TBL] [Abstract][Full Text] [Related]
2. [Predictive model for hygroscopicity of contents in Guizhi Fuling Capsules].
Wang Q; Xu B; Wang F; Xu FF; Zhang X; Zhang YC; DU H; Xia CY; Bao LW; Wang ZZ; Qiao YJ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(2):242-249. PubMed ID: 32237305
[TBL] [Abstract][Full Text] [Related]
3. [Simultaneous determination of six triterpenoid acids from Guizhi Fuling capsules by UPLC-MS/MS].
Ma Y; Li JC; Huang WZ; Wang ZZ; Xiao W; Song YL; Zhang YW
Zhongguo Zhong Yao Za Zhi; 2017 Sep; 42(17):3368-3373. PubMed ID: 29192448
[TBL] [Abstract][Full Text] [Related]
4. [Study of integrative evidence chain in clinical trial of Guizhi Fuling Capsules based on "Yibing Tongzhi" in clinical applications].
Gao Y; Wang GQ; Xie YM; Wei RL; Liu FM
Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2304-2309. PubMed ID: 32495585
[TBL] [Abstract][Full Text] [Related]
5. Guizhi Fuling Formulation: A review on chemical constituents, quality control, pharmacokinetic studies, pharmacological properties, adverse reactions and clinical applications.
Liu X; Chen L; Sun P; Zhan Z; Wang J
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117277. PubMed ID: 37802375
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study on dissolution behavior of Fufang Danshen Pian].
Zhang Q; Li Z; Qu HB; Li WL
Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(8):1918-1923. PubMed ID: 32489078
[TBL] [Abstract][Full Text] [Related]
7. [Quality analysis of Guizhi Fuling capsule before and after application of in-process quality control in pharmaceutical production].
Li JC; Wang JL; Wu JL; Huang WZ; Wang ZZ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1017-22. PubMed ID: 26226737
[TBL] [Abstract][Full Text] [Related]
8. [Discrete element simulation study of mixing process of Guizhi Fuling Capsules: parameter calibration].
Li HZ; Tang XF; Lin Y; Xu FF; Zhang X; Ye HQ; Xiao W; Wang ZZ; Xu B
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(15):4007-4014. PubMed ID: 37802768
[TBL] [Abstract][Full Text] [Related]
9. A multi-evaluating strategy for Weikangling capsules: Chemical profiling, fingerprinting combined with quantitative analysis, quantity transfer, and dissolution curve.
Liu F; Ding H; Wang M; Li X
J Pharm Biomed Anal; 2021 Nov; 206():114347. PubMed ID: 34536823
[TBL] [Abstract][Full Text] [Related]
10. [Literature research and status analysis on clinical application of Guizhi Fuling Formula].
Zhang W; Song DR; Lin KL; Wang XX; Wei L; Xing J
Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(23):5789-5796. PubMed ID: 33496120
[TBL] [Abstract][Full Text] [Related]
11. [Identification of chemical constituents in Guizhi Fuling Capsules by UPLC-Q-TOF-MS/MS].
Yang HM; Yang B; Hu YM; Cao L; Wang ZZ; Zhu KJ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(4):861-877. PubMed ID: 32237487
[TBL] [Abstract][Full Text] [Related]
12. [Analysis on 1 500 adverse reactions of Guizhi Fuling Capsules based on spontaneous response system].
Wei RL; Xie YM; Zhang WL
Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(7):1497-1502. PubMed ID: 31090310
[TBL] [Abstract][Full Text] [Related]
13. [Quality evaluation of guizhi fuling capsule using self-control method of reference Chinese medicine preparation].
Geng T; Zhang ZJ; Li YJ; Ding G; Bi YA; Wang ZZ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(21):4127-32. PubMed ID: 25775780
[TBL] [Abstract][Full Text] [Related]
14. [Dissolution of tanshinone IIA from xianling gubao capsule].
Du S; Chen W; Wu Q; Wu H; Chen X
Zhongguo Zhong Yao Za Zhi; 2010 Jul; 35(13):1706-9. PubMed ID: 20862962
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics Study of Guizhi Fuling Capsules in Rats With Cold Coagulation Dysmenorrhea.
Zhang Y; Su N; Liu W; Wang Q; Sun J; Peng Y
Front Pharmacol; 2021; 12():764904. PubMed ID: 34776980
[TBL] [Abstract][Full Text] [Related]
16. [Guizhi Fuling capsule / pill treatment for chronic pelvic inflammatory disease：a systematic review of randomized clinical trials].
Zhang LS; Yang FW; Zhang JH; Zheng WK; Zhang MY; Li Y; Zhao HJ
Zhongguo Zhong Yao Za Zhi; 2017 Apr; 42(8):1500-1509. PubMed ID: 29071853
[TBL] [Abstract][Full Text] [Related]
17. [The simultaneous determination of laetrile, paeoniflorin and paeonol in Jingzhi Guizhi Fuling capsule by HPLC].
Liao ZG; Ling Y; Zhong Y; Ping QN
Zhongguo Zhong Yao Za Zhi; 2005 Aug; 30(16):1252-4. PubMed ID: 16245901
[TBL] [Abstract][Full Text] [Related]
18. [Dissolution determination of Shuanghuanglian capsules by HPLC analysis assisted with principal component analysis].
Zhang WQ; Guo HZ; Zhang XQ; Liu QY
Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(7):985-9. PubMed ID: 23847942
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of ultra-high performance supercritical fluid chromatography method for quantitative determination of six compounds in Guizhi Fuling capsule and tablet samples.
Li BQ; Li XK; Lin Y; Li ZY; Zhang XZ; Feng N; Ma AJ; Chen CY; Tan LF
J Sep Sci; 2021 Sep; 44(17):3199-3207. PubMed ID: 34213832
[TBL] [Abstract][Full Text] [Related]
20. [Application of microwave technology in extraction process of Guizhi Fuling capsule].
Wang ZK; Zhou M; Liu Y; Bi YA; Wang ZZ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2015 Jun; 40(11):2123-7. PubMed ID: 26552167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
